Lumexa Imaging Holdings Inc. Common Stock (LMRI)

FairStock Score: 35/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for durable economics, honest accounting, and a price that leaves room for error. Lumexa operates diagnostic imaging centers, a business with steady demand but heavy equipment, real estate, and payer pressure. It is not a classic moat business; scale and referral relationships matter, but patients and insurers can shop around, and reimbursement is largely set by others. The recent filings show progress: in fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $264.2 million and net income was $2.7 million, or diluted EPS of $0.03. That compares with fiscal Q2 2025, the quarter ended 2025-06-30, when revenue was $251.4 million and net loss was $7.2 million. In fiscal Q1 2026, the quarter ended 2026-03-31, revenue was $252.5 million and net income was $1.7 million, versus a net loss of $7.7 million in fiscal Q1 2025, the quarter ended 2025-03-31. So the trend is real, but margins are razor-thin; the latest quarter's net margin was only 1.04%. At the 2026-10-13 close, FairStock shows a negative trailing P/E, a P/B of 1.66, ROCE of 1.88%, ROE of -12.60%, and debt-to-equity of 1.59. Free cash flow is $31.2 million, a 3.1% yield at that close, which is not generous. The Piotroski F-Score is 9/9, suggesting accounting improvement, but the Altman Z-Score is 0.23, warning of financial fragility. EV/EBITDA is 14.57, not cheap for a low-return, leveraged business. The FairStock score is 35/100, and the Lynch category is none because there are only 0 years of filed annual results. I would want several more quarters of profitable growth and debt reduction before calling this a bargain. The price may be fair, but the business quality and balance sheet keep me cautious.

In plain English: Lumexa Imaging Holdings runs outpatient diagnostic imaging centers in the United States, offering MRI, CT, PET, X-ray, ultrasound, and mammography services. The business has recently shown small profits after losses a year earlier, but profits are very thin and the company carries a lot of debt. At $10.61, the price looks neither clearly cheap nor clearly expensive based on the numbers given.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · fiscal Q1 2025 10-Q (period ended 2025-03-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer